HPLC vs Mass Spectrometry: How Peptide Purity and Identity Are Tested

Reversed-phase HPLC and mass spectrometry answer two different questions about a peptide sample: HPLC reports purity as the area percentage of the main peak, and mass spectrometry confirms identity by matching an observed mass to the mass calculated from the molecular formula. A sample can be 99% pure by HPLC and still be the wrong compound, and it can have the right mass and still be impure, which is why an analytical report carries both results.

What does HPLC measure?

High-performance liquid chromatography (HPLC) measures purity: the share of a sample's integrated peak area that belongs to the main peak. For peptides the standard mode is reversed-phase HPLC (RP-HPLC). A dissolved sample is pumped through a C18 column with a water/acetonitrile mobile phase, usually containing 0.1% trifluoroacetic acid or formic acid, and components elute in order of hydrophobicity as the acetonitrile fraction rises. A UV detector, usually set at 214 or 220 nm where the peptide bond absorbs, records detector response against retention time, and each component appears as a peak.

Purity is the main peak's area divided by the total integrated peak area, times 100. A result of 99.2% means that 99.2% of the integrated peak area belongs to the main peak; the remaining 0.8% is peptide-related impurities such as deletion sequences, truncated sequences, oxidized methionine or deamidated asparagine. HPLC purity is a relative figure, not an assay: an assay is absolute content measured against a reference standard. Water, counter-ion and residual salts are not counted in an area-percent purity. The full method, including gradient and wavelength, is in HPLC purity of research peptides.

What does mass spectrometry measure?

Mass spectrometry (MS) measures identity: it ionizes the peptide, measures the mass-to-charge ratio (m/z) of the ions, and converts the result to an observed molecular mass. That observed mass is compared with the theoretical mass calculated from the molecular formula. If the two agree within the instrument tolerance, about ±0.1% for low-resolution electrospray instruments, the identity is confirmed. Mass agreement confirms the elemental composition; it does not establish the order of the residues, which a sequence with the same composition in a different order would share and which only fragmentation (MS/MS) data can show. The composition test also separates end-group analogues from their parent: N-Acetyl Semax Amidate 10mg carries an N-terminal acetyl and a C-terminal amide that Semax lacks, so its formula is C39H54N10O10S and its listed mass 854.98 Da, against 813.90 Da for Semax. A second heptapeptide, Selank 10mg, C33H57N11O9, listed at 751.87 Da, gives [M+H]⁺ at m/z 752.88 computed from the listing value.

BPC-157 is a worked example. Its formula C62H98N16O22 gives a molecular weight of 1419.53 Da (PubChem CID 9941957, CAS 137525-51-0), so a report that confirms identity shows an observed mass within about 1.4 Da of 1419.53. The same formula gives a monoisotopic mass of 1418.70 Da, computed from the formula; a high-resolution instrument resolves that monoisotopic peak, a low-resolution instrument reports the average, and the report states which one it compared. Counter-ions dissociate on ionization, so the observed mass is that of the peptide whatever the salt form. Charge states, deconvolution and tolerances are covered in mass spectrometry identity confirmation, and expected values for every listed compound are in the expected mass table.

Why does a peptide report need both HPLC and mass spectrometry?

A peptide report needs both because each technique is blind to the question the other answers. HPLC cannot name the compound in its main peak: a retention time identifies nothing on its own, and a wrong peptide or a synthesis by-product can give one clean, dominant peak. Mass spectrometry cannot give a purity figure: different species ionize with different efficiency, so peak heights in a mass spectrum are not proportional to the amount of each species present.

Neither technique measures the mass of peptide in a vial. Water, trifluoroacetate or acetate counter-ion and residual salts are invisible to both, which is why net peptide content is a separate measurement, explained in how net peptide content is determined and TFA vs acetate salts.

What does an HPLC chromatogram show?

A chromatogram plots detector response against retention time; the report integrates each peak, and purity is the main peak's area divided by the total integrated area. A reversed-phase chromatogram of a peptide sample shows one main peak for the target sequence, a baseline, and any secondary peaks from peptide-related impurities such as deletion or truncated sequences and oxidized residues. The retention time of the main peak is comparable only with runs made on the same column, mobile phase, gradient and flow rate. When a stated purity is high but the trace shows large secondary peaks, the stated figure and the chromatogram disagree, and the peak table shows the integrated areas.

Which mass-spectrometry techniques appear on peptide reports?

Two ionization techniques appear on research peptide reports: electrospray ionization (ESI) and matrix-assisted laser desorption/ionization with time-of-flight detection (MALDI-TOF).

ESI-MS (electrospray ionization) produces multiply charged ions. For an ion carrying z protons, m/z = (M + z × 1.00728) / z. Computed from the listing value of 1419.53 Da, BPC-157 gives [M+H]⁺ at m/z 1420.54 and [M+2H]²⁺ at m/z 710.77. TB-500, the 43-residue N-acetylated thymosin beta-4 listed at 4963.44 Da (CAS 77591-33-4, PubChem CID 16132341), gives [M+4H]⁴⁺ at m/z 1241.87 and [M+5H]⁵⁺ at m/z 993.70. At the short end, the tetrapeptide Livagen 20mg, listed at 461.47 Da (C18H31N5O9), gives [M+H]⁺ at m/z 462.48 and [M+2H]²⁺ at m/z 231.74 computed from the listing value, as for BPC-157 above. Software deconvolutes the charge-state series back to one neutral mass, which is the figure a report compares with the theoretical value.

MALDI-TOF (matrix-assisted laser desorption/ionization, time of flight) produces singly charged ions, so the main peak sits at [M+H]⁺: about m/z 4964.45 for TB-500, computed from the same listing value. It is often used for longer sequences, such as the 43-residue TB-500. At 4963.44 Da, a ±0.1% tolerance is about ±5 Da, so the acceptable window widens with the size of the peptide. The 28-residue Thymosin Alpha-1 10mg, listed at 3108.26 Da (CAS 62304-98-7, PubChem CID 16130571), is another sequence long enough for MALDI-TOF, with [M+H]⁺ at about m/z 3109.27 and a ±0.1% window of about ±3.1 Da.

How is an HPLC and mass-spectrometry result checked on a report?

1. Confirm that the compound name, molecular formula and molecular weight on the report match the listing and the PubChem or CAS record.
2. Find the chromatogram and its peak table, and check that the main peak's area divided by the total integrated area gives the stated purity.
3. Note the column, gradient and detection wavelength; a purity figure or retention time is comparable only with runs under the same stated conditions.
4. Compare the observed mass with the theoretical mass, noting whether the report compared monoisotopic or average mass, and check that the difference falls within about ±0.1% for a low-resolution instrument.
5. For an ESI spectrum, convert the listed m/z values with their charge states and confirm they point to the same neutral mass.

The full field-by-field walk-through is in how to read and verify a peptide COA.

What does Pepta Labs' report contain?

The analytical report (COA) for the sampled production run includes both RP-HPLC purity and MS identity results from an independent laboratory commissioned through a cooperative purchasing group; Pepta Labs does not test in-house. The reported HPLC purity is shown on each product page, and reports are available upon request by email. See our purity testing explained for more detail.

In the site's standard wording, the testing represented is “Independent third-party HPLC purity analysis and mass-spectrometry identity confirmation, commissioned through the purchasing group on a sampled production run from the source. Pepta Labs does not test in-house.” On the report itself: “Because testing is commissioned by the purchasing group, the client field may name the group or source rather than Pepta Labs, and supplier-identifying fields are redacted.” On the vial: “Vial labels identify the compound, quantity and research-use designation. They do not carry lot or batch numbers.” Net peptide content is not reported per listing. “Sterility, endotoxin or LAL, potency, pharmaceutical-grade, cGMP, contaminant-panel and vial fill-quantity testing are not claimed.” Reports are sent by email on request, before or after ordering; the quality page explains how to ask for one.

The same two results are represented for the incretin listings, for example retatrutide 20 mg from $104.86; vial sizes are compared in retatrutide vial sizes and prices. Those listings are not paid through the online card checkout: the order is reserved and the payment options are listed on the next page and in the confirmation email.

Frequently asked questions

Can a peptide pass mass spectrometry and fail HPLC?

Yes. The main peak can have the expected mass while secondary peaks make up a large share of the chromatogram, so the identity is confirmed but the purity is low.

Can a peptide pass HPLC and fail mass spectrometry?

Yes. A chromatogram with one dominant peak says the material is uniform, and only the mass spectrum shows whether that peak is the expected molecule.

Which technique gives the purity percentage on a product page?

Reversed-phase HPLC. The figure is the main peak's share of total integrated peak area on the laboratory's report for the sampled run; it is not a mass-spectrometry result and not a net peptide content.

How do ESI and MALDI differ on a peptide report?

ESI ionizes from solution and gives a series of multiply charged ions that are deconvoluted to one mass, while MALDI-TOF usually gives a singly charged ion. For TB-500 at 4963.44 Da, ESI shows ions such as m/z 993.70 (5+) and 1241.87 (4+), and MALDI-TOF shows [M+H]⁺ near m/z 4964.45.

What is LC-MS, and how does it relate to HPLC and MS?

LC-MS couples a liquid chromatograph directly to a mass spectrometer, so the peaks separated on the column pass into the mass spectrometer and each can be assigned a mass. The purity percentage is still taken from the integrated UV chromatogram, and the mass spectrum of the main peak gives the identity result.

Which tests does Pepta Labs represent?

RP-HPLC purity and MS identity for a sampled production run, from an independent laboratory. Sterility, endotoxin or LAL, potency, pharmaceutical-grade, cGMP, contaminant-panel and vial fill-quantity testing are not claimed.

Sources

• USP General Chapter <621> Chromatography.
• USP General Chapter <736> Mass Spectrometry.
• PubChem compound record CID 9941957 (BPC-157, C62H98N16O22).
• PubChem compound record CID 16132341 (thymosin beta-4, N-acetylated, 43 residues).

All products are supplied for laboratory research use only and are not for human or animal use.